Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

October 2017 Liquidating Trust — Surface Oncology, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / October 2017 Liquidating Trust

October 2017 Liquidating Trust

See Remark 1 at Surface Oncology, Inc. · on record since Apr 25, 2018
10% owner at Surface Oncology, Inc. · on record since Apr 18, 2018

Insider trading activity of October 2017 Liquidating Trust

Transactions on record: 2; since Apr 25, 2018

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 25, 2018

Figures computed from official regulatory filings — methodology.

Companies where October 2017 Liquidating Trust has traded

Surface Oncology, Inc.2 tx · Apr 25, 2018

Track record of October 2017 Liquidating Trust

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of October 2017 Liquidating Trust

Co-insiders of October 2017 Liquidating Trust

Adams ChandraSurface Oncology, Inc.
Atlas Venture Associates IX, LLCSurface Oncology, Inc.
Atlas Venture Associates IX, L.P.Surface Oncology, Inc.
Atlas Venture Fund IX, L.P.Surface Oncology, Inc.
BARRETT M JAMESSurface Oncology, Inc.
BARRIS PETER JSurface Oncology, Inc.
BASKETT FORESTSurface Oncology, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Boni TheresaSurface Oncology, Inc.

Brunn CarstenSurface Oncology, Inc.

Chappel Scott CSurface Oncology, Inc.

Dwyer WendySurface Oncology, Inc.

EcoR1 Capital, LLCSurface Oncology, Inc.

FEES JESSICASurface Oncology, Inc.

FIL LtdSurface Oncology, Inc.

Florence Anthony A. Jr.Surface Oncology, Inc.

FMR LLCSurface Oncology, Inc.

Goater JeffSurface Oncology, Inc.

GRAYZEL DAVID S.Surface Oncology, Inc.

Hall Steven EdwardSurface Oncology, Inc.

Hickey BenjaminSurface Oncology, Inc.

Ibrahim RamySurface Oncology, Inc.

Kearney Michael JSurface Oncology, Inc.

KERINS PATRICK JSurface Oncology, Inc.

Lilly Ventures Fund I LLCSurface Oncology, Inc.

LV Management Group, LLCSurface Oncology, Inc.

LYNCH DANIELSurface Oncology, Inc.

MCDONOUGH GEOFFSurface Oncology, Inc.

MOTT DAVID MSurface Oncology, Inc.

NEA 14 GP, LTDSurface Oncology, Inc.

NEA Partners 14, L.P.Surface Oncology, Inc.

New Enterprise Associates 14, L.P.Surface Oncology, Inc.

Nogelo Liisa ISurface Oncology, Inc.

NOVARTIS AGSurface Oncology, Inc.

Novartis Institutes for BioMedical Research, Inc.Surface Oncology, Inc.

ONEILL ALISONSurface Oncology, Inc.

Palombella Vito J.Surface Oncology, Inc.

RATH HENRY C.Surface Oncology, Inc.

ROSS ROBERT W.Surface Oncology, Inc.

SANDELL SCOTT DSurface Oncology, Inc.

Shanafelt ArmenSurface Oncology, Inc.

Sigal Charles ElliottSurface Oncology, Inc.

Sonsini Peter W.Surface Oncology, Inc.

Stelzer LaurieSurface Oncology, Inc.

Torres DeniceSurface Oncology, Inc.

Torres S. EdwardSurface Oncology, Inc.

Viswanathan RaviSurface Oncology, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Surface Oncology, Inc.	Apr 25, 2018	OtherD	-893,450	—	—	SEC
Surface Oncology, Inc.	Apr 25, 2018	Other	406,113	—	—	SEC